Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • The following terms were not found in PubMed: review literature[mh], consumerj[sb].
  • See the search details.

Results: 1 to 20 of 1209

1.

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial.

Howe CL, Bergstrom RA, Horazdovsky BF.

Neurology. 2009 Oct 13;73(15):1247; author reply 1247-8. No abstract available. PMID: 19822878 [PubMed - indexed for MEDLINE]Related articles

2.

Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, Shoesmith C, Strong MJ, Woolley SC; Quality Standards Subcommittee of the American Academy of Neurology.

Neurology. 2009 Oct 13;73(15):1227-33. Review.PMID: 19822873 [PubMed - indexed for MEDLINE]Related articles

3.

Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, Shoesmith C, Strong MJ, Woolley SC; Quality Standards Subcommittee of the American Academy of Neurology.

Neurology. 2009 Oct 13;73(15):1218-26. Review.PMID: 19822872 [PubMed - indexed for MEDLINE]Related articles

4.

Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis.

Piepers S, Veldink JH, de Jong SW, van der Tweel I, van der Pol WL, Uijtendaal EV, Schelhaas HJ, Scheffer H, de Visser M, de Jong JM, Wokke JH, Groeneveld GJ, van den Berg LH.

Ann Neurol. 2009 Aug;66(2):227-34.PMID: 19743466 [PubMed - indexed for MEDLINE]Related articles

5.

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.

Kaufmann P, Thompson JL, Levy G, Buchsbaum R, Shefner J, Krivickas LS, Katz J, Rollins Y, Barohn RJ, Jackson CE, Tiryaki E, Lomen-Hoerth C, Armon C, Tandan R, Rudnicki SA, Rezania K, Sufit R, Pestronk A, Novella SP, Heiman-Patterson T, Kasarskis EJ, Pioro EP, Montes J, Arbing R, Vecchio D, Barsdorf A, Mitsumoto H, Levin B; QALS Study Group.

Ann Neurol. 2009 Aug;66(2):235-44.PMID: 19743457 [PubMed - indexed for MEDLINE]Related articles

6.

ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration.

Ravits JM, La Spada AR.

Neurology. 2009 Sep 8;73(10):805-11. Review.PMID: 19738176 [PubMed - indexed for MEDLINE]Related articles

7.

Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system.

Vickers JC, King AE, Woodhouse A, Kirkcaldie MT, Staal JA, McCormack GH, Blizzard CA, Musgrove RE, Mitew S, Liu Y, Chuckowree JA, Bibari O, Dickson TC.

Brain Res Bull. 2009 Oct 28;80(4-5):217-23. Epub 2009 Aug 13. Review.PMID: 19683034 [PubMed - indexed for MEDLINE]Related articles

8.

Motor cortex stimulation for ALS: a double blind placebo-controlled study.

Di Lazzaro V, Pilato F, Profice P, Ranieri F, Musumeci G, Florio L, Beghi E, Frisullo G, Capone F, Sabatelli M, Tonali PA, Dileone M.

Neurosci Lett. 2009 Oct 16;464(1):18-21. Epub 2009 Aug 12.PMID: 19682544 [PubMed - indexed for MEDLINE]Related articles

9.

Autophagy, lithium, and amyotrophic lateral sclerosis.

Pasquali L, Longone P, Isidoro C, Ruggieri S, Paparelli A, Fornai F.

Muscle Nerve. 2009 Aug;40(2):173-94. Review.PMID: 19609902 [PubMed - indexed for MEDLINE]Related articles

10.

Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis.

Seetharaman SV, Prudencio M, Karch C, Holloway SP, Borchelt DR, Hart PJ.

Exp Biol Med (Maywood). 2009 Oct;234(10):1140-54. Epub 2009 Jul 13. Review.PMID: 19596823 [PubMed - indexed for MEDLINE]Related articles

11.

Biomarkers in amyotrophic lateral sclerosis: facts and future horizons.

Pradat PF, Dib M.

Mol Diagn Ther. 2009;13(2):115-25. doi: 10.2165/01250444-200913020-00005. Review.PMID: 19537846 [PubMed - indexed for MEDLINE]Related articles

12.

Managing patients with amyotrophic lateral sclerosis.

Sathasivam S.

Eur J Intern Med. 2009 Jul;20(4):355-8. Epub 2008 Oct 11. Review.PMID: 19524172 [PubMed - indexed for MEDLINE]Related articles

13.

Axon guidance proteins: novel therapeutic targets for ALS?

Schmidt ER, Pasterkamp RJ, van den Berg LH.

Prog Neurobiol. 2009 Aug;88(4):286-301. Epub 2009 Jun 10. Review.PMID: 19523502 [PubMed - indexed for MEDLINE]Related articles

14.

Defining survival as an outcome measure in amyotrophic lateral sclerosis.

Gordon PH, Corcia P, Lacomblez L, Pochigaeva K, Abitbol JL, Cudkowicz M, Leigh PN, Meininger V.

Arch Neurol. 2009 Jun;66(6):758-61.PMID: 19506136 [PubMed - indexed for MEDLINE]Related articles

15.

Incidence and prevalence of amyotrophic lateral sclerosis in Canada: a systematic review of the literature.

Wolfson C, Kilborn S, Oskoui M, Genge A.

Neuroepidemiology. 2009;33(2):79-88. Epub 2009 May 30. Review.PMID: 19494548 [PubMed - indexed for MEDLINE]Related articles

16.

Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort.

Gallo V, Bueno-De-Mesquita HB, Vermeulen R, Andersen PM, Kyrozis A, Linseisen J, Kaaks R, Allen NE, Roddam AW, Boshuizen HC, Peeters PH, Palli D, Mattiello A, Sieri S, Tumino R, Jiménez-Martín JM, Díaz MJ, Suarez LR, Trichopoulou A, Agudo A, Arriola L, Barricante-Gurrea A, Bingham S, Khaw KT, Manjer J, Lindkvist B, Overvad K, Bach FW, Tjønneland A, Olsen A, Bergmann MM, Boeing H, Clavel-Chapelon F, Lund E, Hallmans G, Middleton L, Vineis P, Riboli E.

Ann Neurol. 2009 Apr;65(4):378-85.PMID: 19399866 [PubMed - indexed for MEDLINE]Related articles

17.

Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models.

Dupuis L, Loeffler JP.

Curr Opin Pharmacol. 2009 Jun;9(3):341-6. Epub 2009 Apr 20. Review.PMID: 19386549 [PubMed - indexed for MEDLINE]Related articles

18.

Can we eliminate placebo in ALS clinical Trials?

Simmons Z.

Muscle Nerve. 2009 Jun;39(6):861-5.PMID: 19382170 [PubMed - indexed for MEDLINE]Related articles

19.

A placebo arm is not always necessary in clinical trials of amyotrophic lateral sclerosis.

Gordon PH.

Muscle Nerve. 2009 Jun;39(6):858-60.PMID: 19382169 [PubMed - indexed for MEDLINE]Related articles

20.

Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis.

Vucic S, Kiernan MC.

Curr Mol Med. 2009 Apr;9(3):255-72. Review.PMID: 19355908 [PubMed - indexed for MEDLINE]Related articles

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Find related data

Search details

» See more...